Abstract
US demand to increase 4% annually through 2011
US demand for infection prevention products and services is forecast to rise
4.0 percent annually to $15.6 billion in 2011. Mandatory state reporting
requirements along with recommendations developed by the AORN, CDC, FDA, OSHA
and JCAHO will lead to a widespread upgrading of infection prevention
safeguards throughout the health care and life science sectors. Although long
recognized as a problem, the transmission of disease-causing pathogens during
patient procedures persists through the health care community. These failures
are attributable directly to cost containment pressures that have discouraged
facilities from elevating infection prevention to a major departmental
function.
Study coverage
It presents historical data plus forecasts for 2011 and 2016 for supplies,
equipment and services by type and market. This US study analyzes the market
environment, examines trends in medical product regulation, and assesses new
product development. In addition, it also evaluates company market share and
profiles 23 US industry competitors.
View Cart
